1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Main Authors: | Jun Zhang, Kai Sun, Maen Abdelrahim, Zimu Gong, Yuqi Zhang, Catherine Wiechmann, Jiaqiong Xu, Ethan Burns, Ryan Kieser, Ibrahim Muhsen, Shivan Shah, Godsfavour Umoru, Aubrey Crenshaw, Abdullah Esmail, Kelly Gee, Monisha Singh, Eleni Efstathiou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
by: Jun Zhang, et al.
Published: (2023-11-01) -
451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab
by: Kai Sun, et al.
Published: (2023-11-01) -
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
by: Ethan A. Burns, et al.
Published: (2022-12-01) -
Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
by: Emaan Haque, et al.
Published: (2022-12-01) -
Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report
by: Maen Abdelrahim, et al.
Published: (2022-06-01)